Repligen (RGEN) Cost of Revenue (2010 - 2026)

Repligen (RGEN) has 17 years of Cost of Revenue data on file, last reported at $86.0 million in Q1 2026.

• Quarterly Cost of Revenue rose 10.5% year-over-year to $86.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.6 million (changed 0.45% YoY) and the FY2025 annual result came in at $352.0 million, down 2.16% from the prior year.
• Cost of Revenue slipped to $86.0 million in Q1 2026 per RGEN's latest filing, from $94.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $128.7 million in Q4 2024 and bottomed at $76.4 million in Q1 2024.
• The 5-year median for Cost of Revenue is $86.3 million (2022), against an average of $88.1 million.
• The widest annual swing landed in 2024, when Cost of Revenue surged 46.03%; it then dropped 26.9% in 2025.
• Tracing RGEN's Cost of Revenue over 5 years: stood at $90.7 million in 2022, then decreased by 2.83% to $88.1 million in 2023, then surged by 46.03% to $128.7 million in 2024, then retreated by 26.9% to $94.1 million in 2025, then fell by 8.62% to $86.0 million in 2026.
• Per Business Quant, the three latest RGEN Cost of Revenue figures stand at $86.0 million (Q1 2026), $94.1 million (Q4 2025), and $88.3 million (Q3 2025).

Peer Comparison